Rezultati

eNauka >  Results >  Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results
Title: Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results
Authors : O'Shaughnessy, J; ...; Popovic, Lazar S  ; ...; Vojnovic, Z; ...; Milenkovic, D; ...; (broj, koautora 23)
Issue Date: 2019
Publication: CANCER RESEARCH
ISSN: 0008-5472 Cancer Research Search Idenfier
Type: Conference Paper
Collation: vol. 79 br. 4 str. PD1-01
DOI: 10.1158/1538-7445.SABCS18-PD1-01
WoS-ID: 000478677002380
URI: https://enauka.gov.rs/handle/123456789/821404
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
OpenCitations
1
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.